BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1410135)

  • 21. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
    Mavridis M; Besson MJ
    Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens.
    Churchill L; Dilts RP; Kalivas PW
    Brain Res; 1990 Mar; 511(1):41-54. PubMed ID: 2158856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W; Neill DB; Lynn M; Justice JB
    Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance P attenuates and DAMGO potentiates amygdala glutamatergic neurotransmission within the ventral pallidum.
    Mitrovic I; Napier TC
    Brain Res; 1998 May; 792(2):193-206. PubMed ID: 9593891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumbal core: essential link in feed-forward spiraling striato-nigro-striatal in series connected loop.
    Ikeda H; Koshikawa N; Cools AR
    Neuroscience; 2013 Nov; 252():60-7. PubMed ID: 23933312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors.
    Churchill L; Roques BP; Kalivas PW
    Psychopharmacology (Berl); 1995 Aug; 120(3):347-55. PubMed ID: 8524983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity.
    Jones DL; Mogenson GJ
    Am J Physiol; 1980 Jan; 238(1):R65-9. PubMed ID: 7356049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apomorphine decreases extracellular GABA in the ventral pallidum of rats with 6-OHDA lesions in the nucleus accumbens.
    Bourdelais A; Kalivas PW
    Brain Res; 1992 Apr; 577(2):306-11. PubMed ID: 1606502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry.
    Swerdlow NR; Koob GF
    Brain Res; 1987 Jun; 412(2):233-43. PubMed ID: 3607466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of locomotor and conditioned place preference responses following manipulation of GABA-A and AMPA receptors in ventral pallidum.
    Gong W; Justice JB; Neill D
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):839-52. PubMed ID: 9278955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens.
    Longoni R; Spina L; Mulas A; Carboni E; Garau L; Melchiorri P; Di Chiara G
    J Neurosci; 1991 Jun; 11(6):1565-76. PubMed ID: 1646295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.
    Klitenick MA; Wirtshafter D
    J Pharmacol Exp Ther; 1995 Apr; 273(1):327-36. PubMed ID: 7714785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D1 receptors and adenosine A1 receptors in the rat nucleus accumbens regulate motor activity but not prepulse inhibition.
    Schwienbacher I; Fendt M; Hauber W; Koch M
    Eur J Pharmacol; 2002 May; 444(3):161-9. PubMed ID: 12063076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMDA receptor antagonist-induced dopamine release in the ventral pallidum does not correlate with motor activation.
    Kretschmer BD
    Brain Res; 2000 Mar; 859(1):147-56. PubMed ID: 10720624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.